Spontaneous neutrophil activation in HTLV-1 infected patients

Brazilian Journal of Infectious Diseases

Volumn 9, Issue 6, 2005, Pages 510-514

  Guerreiro, Jaqueline B ^a   Porto, Maria Aurélia F ^a   Santos, Silvane B ^a   Lacerda, Lino ^a   Ho, John L ^b   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

HTLV 1; IFN ; LPS; Neutrophil activation; TNF

Indexed keywords

FORMAZAN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITROBLUE TETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKOCYTE ACTIVATION; MONONUCLEAR CELL;

EID: 31144444949     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702005000600010     Document Type: Article

References (23)

1. Edlich R.F., Arnette J.A., Williams F.M. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000;18:109-19.
2. McFarlin D.E., Blattner W.A. Non-AIDS retroviral infections in humans. Annu Rev Med 1991;42:97-105.
3. Biddison W.E., Kubota R., Kawanishi T., et al. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997;159:2018-25.
4. Uchiyama T., Hori T., Tsudo M., et al. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest 1985;76:446-53.
5. Itoyama Y., Minato S., Kira J., et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 1988;38:1302-7.
6. Santos S.B., Porto A.F., Muniz A.L., et al. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 2004;4:7.
7. Dinauer M.C., Lekstrom-Himes J.A., Dale D.C. Inherited neutrophil disorders: Molecular basis and new therapies. Hematology (Am Soc Hematol Edu program) 2000:303-18.
8. Gotuzzo E., Arango C., de Queiroz-Campos A., Isturiz R.E. Human T-cell lymphotropic viras-I in Latin America. Infect Dis Clin North Am 2000;14:211-39.
9. Sato Y., Shiroma Y., Kiyuna S., et al. Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan. Trans R Soc Trop Med Hyg 1994;88:59.
10. Cassatella M.A., Bazzoni F., Flynn R.M., et al. Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J Biol Chem 1990;265:20241-6.
11. Baehner R.L., Boxer L.A., Davis J. The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood 1976;48:309-13.
12. Sonnerborg A., Jarstrand C. Nitroblue tetrazolium (NBT) reduction by neutrophilic granulocytes in patients with HTLV-III infection. Scand J Infect Dis 1986;18:101-3.
13. Osame M., Usuku K., Izumo S., et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;1:1031-2.
14. Park B.H., Holmes B.M., Rodey G.E. and Good R.A. Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants. Lancet 1969;1:157.
15. Bellinati-Pires R., Carneiro-Sampaio M.M., Colletto G.M. Functional evaluation of human neutrophils. Is the bactericidal activity correlated with nitroblue tetrazolium reduction? J Investig Allergol Clin Immunol 1992;2:146-53.
16. Bjorksten B. The influence of technical factors on the NBT test. Scand J Haematol 1974;12:46-50.
17. Valentin H., Lemasson I., Hamaia S., et al. Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein. J Virol 1997;71:8522-30.
18. Knight S.C., Macatonia S.E., Cruickshank K., et al. Dendritic cells in HIV-1 and HTLV-1 infection. Adv Exp Med Biol 1993;329:545-9.
19. Richardson J.H., Edwards A.J., Cruickshank J.K., et al. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990;64:5682-7.
20. Miyatake S., Seiki M., Yoshida M., Arai K. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol Cell Biol 1988;8:5581-7.
21. Jacobson S., Krichavsky M., Flerlage N., Levin M. Immunopathogenesis of HTLV-I associated neurologic disease: massive latent HTLV-I infection in bone marrow of HAM/TSP patients. Leukemia 1997;11 Suppl 3:73-5.
22. Murray H.W., Gellene R.A., Libby D.M., et al. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J Immunol 1985;135:2374-7.
23. Cassatella M.A., Cappelli R., Della Bianca V., et al. Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis. Immunology 1988;63:499-506.